Table 3.
Model 1a | Model 2b | Model 3c | ||||
---|---|---|---|---|---|---|
HR (95% CI) | P-value | HR (95% CI) | P-value | HR (95% CI) | P-value | |
All-cause mortality | ||||||
Continuous NPARd | 2.54 (2.09–3.07) | <0.001 | 1.74 (1.41–2.13) | <0.001 | 1.56 (1.18–2.05) | 0.002 |
Tertile 1 | 1.0 | 1.0 | 1.0 | |||
Tertile 2 | 1.35 (1.06–1.73) | 0.015 | 1.21 (0.94–1.54) | 0.136 | 1.14 (0.85–1.53) | 0.369 |
Tertile 3 | 2.51 (2.01–3.14) | <0.001 | 1.71 (1.36–2.15) | <0.001 | 1.51 (1.14–1.98) | 0.004 |
P for trend | <0.001 | <0.001 | 0.002 | |||
Cardiovascular mortality | ||||||
Continuous NPARd | 2.54 (1.94–3.32) | <0.001 | 1.70 (1.27–2.27) | <0.001 | 1.57 (1.07–2.28) | 0.020 |
Tertile 1 | 1.0 | 1.0 | 1.0 | |||
Tertile 2 | 1.37 (0.97–1.94) | 0.073 | 1.21 (0.85–1.71) | 0.294 | 1.17 (0.77–1.78) | 0.452 |
Tertile 3 | 2.55 (1.86–3.50) | <0.001 | 1.74 (1.26–2.39) | 0.001 | 1.57 (1.07–2.31) | 0.022 |
P for trend | <0.001 | <0.001 | 0.016 |
Notes: aUnadjusted model. bAdjusted for age, gender, body mass index. cAdjusted for model 2 covariates and Charlson comorbidity index, hemoglobin, corrected calcium, phosphorus, total cholesterol, triglycerides, hs-CRP, total Kt/V and residual renal function. dPer unit increment in NPAR levels. P<0.05 is considered statistically significant.
Abbreviations: HR, hazard ratio; CI, confidence interval.